RET and medullary thyroid gland carcinoma: A broad consensus exists only on the pivotal role of calcitonin screening in cases with a family history of MTC or multiple endocrine neoplasia type 2, and its use in guiding the timing of prophylactic thyroidectomy in carriers of RET pathogenic variants [32,33].